Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

FOUR score in monitoring the level of consciousness of an intensive care patient: first experience of the use of the Finnish language version.

Sivula A, Luoto T, Heinilä J, Huhtala H, Karlsson S, Yli-Hankala A, Långsjö J.

Duodecim. 2017;133(11):1081-91.

PMID:
29243901
2.

Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma.

Erkinheimo TL, Sivula A, Lassus H, Heinonen M, Furneaux H, Haglund C, Butzow R, Ristimäki A.

Gynecol Oncol. 2005 Oct;99(1):14-9.

PMID:
16126263
3.

Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus.

Sivula A, Buskens CJ, van Rees BP, Haglund C, Offerhaus GJ, van Lanschot JJ, Ristimäki A.

Int J Cancer. 2005 Oct 10;116(6):903-8.

4.

Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer.

Sivula A, Talvensaari-Mattila A, Lundin J, Joensuu H, Haglund C, Ristimäki A, Turpeenniemi-Hujanen T.

Breast Cancer Res Treat. 2005 Feb;89(3):215-20.

PMID:
15754118
5.

AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.

Voutilainen PE, Siironen P, Franssila KO, Sivula A, Haapiainen RK, Haglund CH.

Anticancer Res. 2003 Sep-Oct;23(5b):4283-8.

PMID:
14666639
6.

Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus.

Buskens CJ, Sivula A, van Rees BP, Haglund C, Offerhaus GJ, van Lanschot JJ, Ristimäki A.

Gut. 2003 Dec;52(12):1678-83.

7.

Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma.

Erkinheimo TL, Lassus H, Sivula A, Sengupta S, Furneaux H, Hla T, Haglund C, Butzow R, Ristimäki A.

Cancer Res. 2003 Nov 15;63(22):7591-4.

8.

Cyclooxygenase-2 and gastric carcinogenesis.

Saukkonen K, Rintahaka J, Sivula A, Buskens CJ, Van Rees BP, Rio MC, Haglund C, Van Lanschot JJ, Offerhaus GJ, Ristimaki A.

APMIS. 2003 Oct;111(10):915-25. Review.

PMID:
14616542
9.

Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines.

van Rees BP, Sivula A, Thorén S, Yokozaki H, Jakobsson PJ, Offerhaus GJ, Ristimäki A.

Int J Cancer. 2003 Nov 20;107(4):551-6.

10.

Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.

Buskens CJ, Van Rees BP, Sivula A, Reitsma JB, Haglund C, Bosma PJ, Offerhaus GJ, Van Lanschot JJ, Ristimäki A.

Gastroenterology. 2002 Jun;122(7):1800-7.

PMID:
12055587
11.

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

Ristimäki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, Joensuu H, Isola J.

Cancer Res. 2002 Feb 1;62(3):632-5.

12.

Long term prognosis of medullary thyroid carcinoma in 39 patients.

Voutilainen PE, Multanen M, Haapiainen RK, Haglund CH, Sane T, Sivula AH.

Ann Chir Gynaecol. 2000;89(4):292-7.

PMID:
11204961
13.

Natural course of adrenal incidentalomas: seven-year follow-up study.

Sirén J, Tervahartiala P, Sivula A, Haapiainen R.

World J Surg. 2000 May;24(5):579-82.

PMID:
10787080
14.

Anaplastic thyroid carcinoma survival.

Voutilainen PE, Multanen M, Haapiainen RK, Leppäniemi AK, Sivula AH.

World J Surg. 1999 Sep;23(9):975-8; discussion 978-9.

PMID:
10449831
15.

The value of ultrasound-guided fine-needle aspiration biopsy (FNAB) and frozen section examination (FS) in the diagnosis of thyroid cancer.

Multanen M, Haapiainen R, Leppäniemi A, Voutilainen P, Sivula A.

Ann Chir Gynaecol. 1999;88(2):132-5.

PMID:
10392250
16.

Laparoscopic adrenalectomy for primary aldosteronism: clinical experience in 12 patients.

Sirén J, Haglund C, Huikuri K, Sivula A, Haapiainen R.

Surg Laparosc Endosc. 1999 Jan;9(1):9-13.

PMID:
9950120
17.

Adrenalectomy for primary aldosteronism: long-term follow-up study in 29 patients.

Sirén J, Välimäki M, Huikuri K, Sivula A, Voutilainen P, Haapiainen R.

World J Surg. 1998 Apr;22(4):418-21; discussion 421-2.

PMID:
9523526
18.

Long-term health risk of primary hyperparathyroidism: the effect of surgery.

Sivula A, Pelkonen R.

Ann Med. 1996 Apr;28(2):95-100. Review.

PMID:
8732636
19.

Incidentalomas of the adrenal gland: 36 operated patients and review of literature.

Sirén JE, Haapiainen RK, Huikuri KT, Sivula AH.

World J Surg. 1993 Sep-Oct;17(5):634-9. Review.

PMID:
8273385
21.

[Endocrine surgery today].

Sivula A.

Nord Med. 1993;108(10):251-3, 262. Swedish.

PMID:
8414942
22.

[Thyroid nodule and its study in Finland].

Välimäki M, Vuorialho E, Bondestam S, Franssila K, Gylling H, Ikkala E, Liewendahl K, Pamilo M, Sivula A, Soiva M.

Duodecim. 1992;108(7):663-9. Finnish. No abstract available.

PMID:
1366127
23.
24.

Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients.

Kukkonen ST, Haapiainen RK, Franssila KO, Sivula AH.

World J Surg. 1990 Nov-Dec;14(6):837-41; discussion 841-2.

PMID:
2256356
25.

Primary gastric non-Hodgkin's lymphoma in Finland, 1972-1977. Clinical presentation and results of treatment.

Jaser N, Sivula A, Franssila K.

Scand J Gastroenterol. 1990 Oct;25(10):1052-9.

PMID:
2263878
26.

New challenges for parathyroid surgery.

Sivula A.

Ann Chir Gynaecol. 1990;79(3):115-6. No abstract available.

PMID:
2264711
27.

Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.

Ekblom M, Välimäki M, Pelkonen R, Jansson R, Sivula A, Franssila K.

Q J Med. 1987 Nov;65(247):899-910.

PMID:
2901773
28.

Natural history of treated primary hyperparathyroidism.

Sivula A, Ronni-Sivula H.

Surg Clin North Am. 1987 Apr;67(2):329-41.

PMID:
3563840
29.

Long-term results of continent ileostomy.

Järvinen HJ, Mäkitie A, Sivula A.

Int J Colorectal Dis. 1986 Jan;1(1):40-3.

PMID:
3598313
30.

Intracranial hematomas studied by MR imaging at 0.17 and 0.02 T.

Sipponen JT, Sepponen RE, Tanttu JI, Sivula A.

J Comput Assist Tomogr. 1985 Jul-Aug;9(4):698-704.

PMID:
4019827
31.

Low field (0.02 T) nuclear magnetic resonance imaging of the brain.

Sepponen RE, Sipponen JT, Sivula A.

J Comput Assist Tomogr. 1985 Mar-Apr;9(2):237-41.

PMID:
3973144
32.

Long-term effect of surgical treatment on the symptoms of primary hyperparathyroidism.

Ronni-Sivula H, Sivula A.

Ann Clin Res. 1985;17(4):141-7.

PMID:
4073802
33.

Observations on 334 patients operated on for primary hyperparathyroidism.

Sivula A, Ronni-Sivula H.

Ann Chir Gynaecol. 1985;74(2):66-73.

PMID:
4026177
34.

Long-term results of adrenal surgery in patients with Cushing's syndrome due to adrenocortical adenoma.

Välimäki M, Pelkonen R, Porkka L, Sivula A, Kahri A.

Clin Endocrinol (Oxf). 1984 Feb;20(2):229-36.

PMID:
6325048
35.

[Principles of magnetic imaging].

Sepponen RE, Sipponen JT, Suoranta HT, Sivula A.

Duodecim. 1984;100(8):463-73. Finnish. No abstract available.

PMID:
6723555
36.

Chronic subdural hematoma: demonstration by magnetic resonance.

Sipponen JT, Sepponen RE, Sivula A.

Radiology. 1984 Jan;150(1):79-85.

PMID:
6689791
37.

The changing picture of primary hyperparathyroidism in the years 1956-1979.

Sivula A, Ronni-Sivula H.

Ann Chir Gynaecol. 1984;73(6):319-24.

PMID:
6529134
38.

Nuclear magnetic resonance (NMR) imaging of intracerebral hemorrhage in the acute and resolving phases.

Sipponen JT, Sepponen RE, Sivula A.

J Comput Assist Tomogr. 1983 Dec;7(6):954-9.

PMID:
6630657
39.

Serial nuclear magnetic resonance (NMR) imaging in patients with cerebral infarction.

Sipponen JT, Kaste M, Ketonen L, Sepponen RE, Katevuo K, Sivula A.

J Comput Assist Tomogr. 1983 Aug;7(4):585-9.

PMID:
6863660
40.

Hyperparathyroidism with hypercalciuria and urolithiasis: long-term effects of parathyroid surgery and postoperative thiazide therapy.

Elomaa I, Sivula A, Kahri A, Puutula-Räsänen L, Pelkonen R.

World J Surg. 1983 Mar;7(2):186-94. No abstract available.

PMID:
6868632
41.

Nuclear magnetic resonance imaging in reversible cerebral ischaemia.

Sipponen JT, Kaste M, Sepponen RE, Kuurne T, Suoranta H, Sivula A.

Lancet. 1983 Feb 5;1(8319):294-5. No abstract available.

PMID:
6130310
42.

Surgical treatment of thyroid carcinoma.

Sivula A.

Ann Chir Gynaecol. 1983;72(3):105-11. No abstract available.

PMID:
6625509
43.

Treatment of pituitary Cushing's disease: results of adrenal and pituitary surgery.

Pelkonen R, Eistola P, Grahne B, Kuusisto A, Paetau A, Sivula A, Valtonen S.

Acta Endocrinol Suppl (Copenh). 1983;251:38-46. No abstract available.

PMID:
6301188
44.

The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior.

Häyry P, Reitamo JJ, Tötterman S, Hopfner-Hallikainen D, Sivula A.

Am J Clin Pathol. 1982 Jun;77(6):674-80.

PMID:
7091047
45.

Familial and sporadic thyroglobulin deficiency with goitre and hypothyroidism.

Wägar G, Lamberg BA, Sivula A, Saarinen P, Mäkinen T.

Ann Clin Res. 1982 Feb;14(1):37-45.

PMID:
7137876
46.

Recurrent adrenal cortical carcinoma with Cushing's syndrome: twenty-five-year follow-up of a patient.

Tikkanen MJ, Sivula A, Kahri A, Pelkonen R.

J Endocrinol Invest. 1980 Oct-Dec;3(4):425-7.

PMID:
7204888
47.

Glucocorticoid receptors in adrenocorticoid disorders.

Kontula K, Pelkonen R, Andersson L, Sivula A.

J Clin Endocrinol Metab. 1980 Sep;51(3):654-7.

PMID:
7410540
48.

Pseudohypoparathyroidism associated with hypercalcitoninaemia.

Wägar G, Lehtivuori J, Salvén I, Backman R, Sivula A.

Acta Endocrinol (Copenh). 1980 Jan;93(1):43-8.

PMID:
7355665
49.

Suppression of the TSH response to TRH by thyroxine therapy in differentiated thyroid carcinoma patients.

Lamberg BA, Rantanen M, Saarinen P, Liewendahl K, Sivula A.

Acta Endocrinol (Copenh). 1979 Jun;91(2):248-56.

PMID:
111446
50.

Radiological assessment of nipple-valve insufficienty in Kock's continent reservoir ileostomy.

Standertskjöld-Nordenstam CG, Palmu A, Sivula A.

Br J Surg. 1979 Apr;66(4):269-72.

PMID:
454996

Supplemental Content

Loading ...
Support Center